 |
According to the Alzheimer’s Association, approximately 5.4 million Americans over the age of 65, or one in eight older adults, have Alzheimer’s disease or other dementias. Alzheimer’s disease is the fifth leading cause of death in Americans aged 65 and older. Medical advances, along with improved social and environmental conditions have resulted in a greater number of Americans living into their 80s and 90s. Because the risk of developing Alzheimer’s disease increases with age, this extended longevity is likely to result in significant increases in the number of individuals with the disease.
Now a study by researchers at Wake Forest Baptist Medical Center suggests that a new manufactured form of insulin delivered in a nasal spray shows potential for improving working memory and mental abilities in older adults with mild cognitive impairment. Short-term ability to retain and process verbal and visual information improved in patients who received insulin detemir. Findings have raised researchers’ hopes of further developing an efficacious treatment.
In addition to reading our e-newsletter, be sure to visit Today’s Geriatric Medicine’s website at www.TodaysGeriatricMedicine.com, where you’ll find news and information that’s relevant and reliable. We welcome your feedback at TGMeditor@gvpub.com. Follow Today’s Geriatric Medicine on Facebook and Twitter, too.
— Barbara Worthington, editor |
 |
 |
New Treatment for Mild Cognitive Impairment?
A manmade form of insulin delivered via nasal spray may improve working memory and other mental capabilities in adults with mild cognitive impairment and Alzheimer’s disease dementia, according to a pilot study led by researchers at Wake Forest Baptist Medical Center.
The study’s subjects were 60 adults diagnosed with amnesic mild cognitive impairment (MCI) or mild to moderate Alzheimer’s dementia (AD). Those who received nasally administered 40 international unit (IU) doses of insulin detemir, a manufactured form of the hormone, for 21 days showed significant improvement in their short-term ability to retain and process verbal and visual information compared with those who received 20 IU doses or a placebo.
Additionally, the recipients of the 40 IU doses who carry the APOE-e4 gene, known to increase the risk for Alzheimer’s, recorded significantly higher memory scores than those who received the lower dosage or placebo, while noncarriers across all three groups posted significantly lower scores.
Full story » |
|
 |
Improving Medication Adherence
Physicians must be proactive in combating medication nonadherence, which results in an estimated total of increased direct and indirect costs of $290 billion per year in avoidable medical spending and lost work productivity. Read more »
Healthy Steps for Older Adults: A Statewide Approach to Preventing Falls
The evidence-based, low-cost, community-based fall risk screening and education program for adults aged 60 and older has been offered through the Pennsylvania Area Agencies on Aging network of senior centers. Read more »
Behavioral Expressions in Dementia Patients
By assessing behavioral expressions exhibited by dementia patients as an individual's attempt to communicate needs, more effective approaches, treatment, and communications with the patient will become more likely. Read more » |
|
|
|
 |
|
|
 |
 |
Lively
Lively provides family members notification when a loved one may need help. Lively's easy-to-use safety watch offers 24/7 emergency response at the push of a button. The simple design allows ease of use. The device's passive activity sensors measure healthful living patterns while advising family members when something may be wrong, such as missed meals, skipped medications, or decreased physical activity. The Lively dashboard can be viewed anywhere with notifications sent by e-mail, text, or mobile app. It requires no computer skills, features automatic updates, and can be set up from a remote location. Learn more »
Rosie Care and Rosie Care3600
Nurse Rosie Products has introduced two negative pressure wound therapy (NPWT) pumps and progressive wound care products. Rosie Care and Rosie Care3600 are the company's new NPWT pumps, which can be used for wounds that are chronic, acute, traumatic, subacute, or dehisced, as well as partial-thickness burns, ulcers (such as diabetic or pressure), flaps, and grafts. Progressive Wound Care's GelTex Black Foam Kits, IodoFoam, and LipoGel are intended to be used with NPWT pump systems. GelTex Black Foam Kits comes in three sizes and can be used with both Rosie Care pumps or with other NPWT systems. IodoFoam is a sterile single-use iodophor foam dressing that is permeated with iodine to create a controlled release of iodophor. LipoGel will not dilute, migrate, or dispense with exudate. It can be used in combination with IodoFoam, and/or Geltex Black Foam kits. Learn more » |
|
 |
 |
A Secure, Anonymous Résumé Bank
Job Alerts Sent to Your E-mail |
|
|
